Hospital AI has become a standard fixture across U.S. health systems, with dashboards tracking infection rates, patient flow, and operational performance now embedded in routine clinical decision-making. Yet despite rapid advances in artificial intelligence, many of the outcomes hospital leaders expected have remained elusive. Healthcare-associated infections still contribute to roughly 72,000 deaths each year in the U.S., according to the most recent CDC data, highlighting the gap between identifying risks and preventing them.
Mohammad Noshad, founder and CEO of Shyld AI, has spent the past several years focused on closing that gap. He believes the challenge stems from a fundamental design choice built into much of today’s healthcare AI. “When a human is involved during cleaning processes and procedures, they are prone to making errors,” Noshad told Healthcare Brew. “We saw an opportunity to bring AI into that space to make it much more efficient and basically automate everything so that you have consistency and efficiency in applying day-to-day disinfection in those hospital areas.”
Rather than simply generating alerts or dashboards, Shyld AI builds autonomous hardware that operates inside hospital rooms, detecting environmental contamination risks and taking autonomous action in real time. Noshad believes AI should do more than provide information, it should solve problems in real time. Shyld AI calls this approach Active AI, and the technology is already deployed in more than 30 U.S. hospitals.
The distinction between AI that reports and AI that executes
Most healthcare AI on the market today observes conditions and produces information about them. The system detects a rising infection risk on a ward, flags it inside a dashboard, and hands the response back to the clinical or environmental services team already working the floor. In Noshad’s view, that architecture keeps most of the operational burden exactly where it started.
Active AI takes a different architectural shape, one built for closing the loop between detection and response. The system senses conditions in the room and executes the required response within the same closed loop, without first asking a clinician to interpret a dashboard. For a hospital leader evaluating any AI investment, the more useful question is whether the technology handles the work itself or generates more work for the team to sort through.
That distinction changes what the AI’s success metrics look like. For Noshad, Active AI is ultimately measured by clinical and operational outcomes, such as reduced contamination rates and lower rates of preventable delay inside the operating room, giving hospital leaders concrete numbers to hold up against the investment. Those outcomes are what hospital budget owners are ultimately answerable for.
Why edge processing changes the value equation
Where AI performs its processing matters as much as what it does. While many AI systems rely on cloud-based infrastructure, Shyld AI’s proprietary VERTEX foundation model runs directly on each device, allowing it to analyze conditions and respond in real time without sending data to the cloud. For Noshad, that architecture is essential inside a hospital room, where speed, reliability, and privacy are critical to delivering meaningful results.
Rather than relying on remote cloud infrastructure for inference, VERTEX processes environmental data directly on the device, enabling the system to perceive conditions, reason locally, and respond in real time. Keeping intelligence on the device enables immediate responses while minimizing the movement of sensitive data beyond the hospital room, helping healthcare organizations address privacy and compliance requirements without compromising performance.
For Noshad, edge-native AI is a foundational part of the company’s broader vision for Active AI. Instead of simply collecting information and waiting for clinicians to respond, Shyld AI’s technology is designed to continuously sense, decide, and act within the clinical environment. By embedding intelligence directly where care is delivered, the company believes hospitals can move beyond passive monitoring toward autonomous systems that improve workflows while reducing operational burden.
Where action-based AI is heading inside hospitals
Noshad believes the market is beginning to reward AI that produces measurable clinical outcomes. A peer-reviewed study conducted at Stanford Hospital’s Advanced Endoscopy Unit, co-authored by Noshad with Stanford researchers Monique T. Barakat and Timothy Angelotti, and published in the American Journal of Infection Control, found that Shyld AI’s autonomous UV-C system reduced cumulative microbial bioburden by more than 93 percent compared with a control room.
The company’s next focus is extending beyond infection control. Inside operating rooms, Shyld AI’s devices already identify missing surgical instruments before procedures begin and surface preventable delays that add cost to a hospital’s operating room budget. Beyond healthcare, the same architecture is beginning to reach pharmaceutical cleanroom environments, where continuous, autonomous contamination control adds direct value.
For Noshad, the shift that matters most to hospital leaders is the move from passive AI to Active AI, technology that understands the hospital environment, responds in real time, and improves workflows without adding burden to clinical teams. As healthcare organizations evaluate their next generation of AI investments, the greatest value will come from systems that do more than observe. The hospitals that see the strongest returns will be those that prioritize AI capable of taking meaningful action, not simply generating more information.
About Shyld AI
Shyld AI is a healthcare technology company bringing physical agentic AI to hospital operations. Founded by CEO and Co-Founder Mohammad Noshad, Shyld AI develops autonomous physical agents that streamline hospital operations like infection control, OR efficiency, and compliance, without adding workload for staff. Its technology combines AI with UV disinfection to reduce environmental contamination by up to 93%. Shyld AI is deployed across hospitals nationwide, improving clinical care, efficiency, and cost savings. To learn more, visit www.shyld.ai/
John Davis is a seasoned health journalist with expertise in public health and medical research. Holding a degree in health sciences, John excels in making complex health topics understandable and engaging for his readers. His articles, featured in top health publications, cover everything from cutting-edge treatments to public health policies. Outside of journalism, John is an advocate for health education and frequently speaks at community events.
